BIO-key CLO receives 250 shares under ESPP
BIO-key International’s Chief Legal Officer, James David Sullivan, acquired 250 shares of Common Stock as a grant under the company’s 2021 Employee Stock Purchase Plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BIO-key International’s Chief Legal Officer, James David Sullivan, acquired 250 shares of Common Stock as a grant under the company’s 2021 Employee Stock Purchase Plan. The shares were credited at a price of $3.83 per share in a transaction classified as a grant or award.
After this transaction, Sullivan directly holds 9,986 shares of BIO-key common stock. The footnotes note that all share amounts reflect BIO-key’s 1-for-10 reverse stock split that became effective on April 30, 2026.
Insider Trade Summary
Grant/Award: 250 shares
Grant/Award
1 txn
Insider
Sullivan James David
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 250 | $3.83 | $957.50 |
Holdings After Transaction:
Common Stock — 9,986 shares (Direct)
Footnotes (2)
- F1. Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2. All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.
Key Figures
Shares acquired: 250 shares
Grant price: $3.83 per share
Total holdings after transaction: 9,986 shares
+1 more
4 metrics
Shares acquired
250 shares
Grant under 2021 Employee Stock Purchase Plan on June 30, 2026
Grant price
$3.83 per share
Price used for ESPP share acquisition
Total holdings after transaction
9,986 shares
Direct common stock ownership after the ESPP grant
Reverse stock split ratio
1-for-10
Reverse split effective April 30, 2026 for all reported share amounts
Key Terms
Employee Stock Purchase Plan, Rule 16b-3(d), Rule 16b-3(c), reverse stock split
4 terms
Employee Stock Purchase Plan financial
"Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(d) regulatory
"in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
reverse stock split financial
"All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BIO KEY INTERNATIONAL INC (BKYI) disclose in this Form 4?
BIO-key reported that Chief Legal Officer James David Sullivan acquired 250 shares of Common Stock. The shares were received as a grant under the 2021 Employee Stock Purchase Plan at $3.83 per share, increasing his direct holdings to 9,986 shares.
What are James David Sullivan’s total BIO KEY (BKYI) holdings after this transaction?
Following the grant, James David Sullivan directly holds 9,986 shares of BIO-key Common Stock. This total already reflects the company’s 1-for-10 reverse stock split that became effective on April 30, 2026, as noted in the Form 4 footnotes.
How did BIO KEY’s reverse stock split affect this Form 4 for BKYI?
The Form 4 states that all share amounts reflect BIO-key’s 1-for-10 reverse stock split effective April 30, 2026. This means both the 250-share grant and the 9,986 total holdings are already adjusted to post-split levels in the disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates